Literature DB >> 14678196

Efficient induction of T helper type 1-mediated immune responses in antigen-primed mice by anti-CD3 single-chain Fv/interleukin-18 fusion DNA.

E J Kim1, D Cho, T S Kim.   

Abstract

Two types of T helper (Th) cells - Th1 and Th2 - play different roles in protection and immunopathology. The Th1 cell-mediated immune response plays an important role in inducing the host defence against intracellular bacteria and also in cancer immunotherapy. To effectively induce Th1 immune responses, we constructed a mammalian expression plasmid (pAnti-CD3sFv/IL-18) carrying a fusion gene in which anti-CD3 single-chain Fv (sFv) cDNA, the smallest unit of antibody recognizing the CD3 epsilon moiety of the T-cell receptor, was covalently linked to mature interleukin (IL)-18 cDNA. Intramuscular injection of ovalbumin (OVA)-sensitized BALB/c mice with pAnti-CD3sFv/IL-18 DNA efficiently increased the production of both OVA-specific interferon-gamma and anti-OVA immunoglobulin G2a, compared to injection with pAnti-CD3sFv DNA. In addition, pAnti-CD3sFv/IL-18 was more efficient than a mixture of pAnti-CD3sFv + pIL-18 in inducing OVA-specific, Th1 immune responses and also in inhibiting OVA-specific, IL-4 production. These studies indicate that vaccination with pAnti-CD3sFv/IL-18 fusion DNA efficiently induces the Th1 immune response in antigen-sensitized mice.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 14678196      PMCID: PMC1782390          DOI: 10.1111/j.1365-2567.2004.01784.x

Source DB:  PubMed          Journal:  Immunology        ISSN: 0019-2805            Impact factor:   7.397


  37 in total

Review 1.  Enhancing immunogenicity by CpG DNA.

Authors:  Weiwen Jiang; David S Pisetsky
Journal:  Curr Opin Mol Ther       Date:  2003-04

Review 2.  Diversity of cytokine synthesis and function of mouse CD4+ T cells.

Authors:  T R Mosmann; J H Schumacher; N F Street; R Budd; A O'Garra; T A Fong; M W Bond; K W Moore; A Sher; D F Fiorentino
Journal:  Immunol Rev       Date:  1991-10       Impact factor: 12.988

3.  Protective immunity is induced in murine colon carcinoma cells by the expression of interleukin-12 or interleukin-18, which activate type 1 helper T cells.

Authors:  K Tasaki; Y Yoshida; T Maeda; M Miyauchi; K Kawamura; K Takenaga; H Yamamoto; T Kouzu; T Asano; T Ochiai; S Sakiyama; M Tagawa
Journal:  Cancer Gene Ther       Date:  2000-02       Impact factor: 5.987

4.  Biological activity and in vivo clearance of antitumor antibody/cytokine fusion proteins.

Authors:  S D Gillies; D Young; K M Lo; S Roberts
Journal:  Bioconjug Chem       Date:  1993 May-Jun       Impact factor: 4.774

Review 5.  Direct gene transfer into muscle.

Authors:  I Danko; J A Wolff
Journal:  Vaccine       Date:  1994-12       Impact factor: 3.641

6.  IL-12 inhibits IL-4 synthesis in keyhole limpet hemocyanin-primed CD4+ T cells through an effect on antigen-presenting cells.

Authors:  R H DeKruyff; Y Fang; S F Wolf; D T Umetsu
Journal:  J Immunol       Date:  1995-03-15       Impact factor: 5.422

7.  Purification of a factor which provides a costimulatory signal for gamma interferon production.

Authors:  K Nakamura; H Okamura; K Nagata; T Komatsu; T Tamura
Journal:  Infect Immun       Date:  1993-01       Impact factor: 3.441

8.  Protection against leishmaniasis by injection of DNA encoding a major surface glycoprotein, gp63, of L. major.

Authors:  D Xu; F Y Liew
Journal:  Immunology       Date:  1995-02       Impact factor: 7.397

9.  Depletion of B cells in vivo by a chimeric mouse human monoclonal antibody to CD20.

Authors:  M E Reff; K Carner; K S Chambers; P C Chinn; J E Leonard; R Raab; R A Newman; N Hanna; D R Anderson
Journal:  Blood       Date:  1994-01-15       Impact factor: 22.113

Review 10.  Immunotherapy of cancer with genetically modified tumor vaccines.

Authors:  E Gilboa
Journal:  Semin Oncol       Date:  1996-02       Impact factor: 4.929

View more
  2 in total

1.  Anti-CD3 sFv/IL-18 fusion DNA for allergy therapy.

Authors:  Maria Salagianni; David M Kemeny
Journal:  Immunology       Date:  2004-01       Impact factor: 7.397

Review 2.  Neovascular Macular Degeneration: A Review of Etiology, Risk Factors, and Recent Advances in Research and Therapy.

Authors:  Arunbalaji Pugazhendhi; Margaret Hubbell; Pooja Jairam; Balamurali Ambati
Journal:  Int J Mol Sci       Date:  2021-01-25       Impact factor: 5.923

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.